.png){kind=logo}
2018
PLoS biology
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
Details
Authors:
Prof. Brigita Lenarčič; retired
Title of the Article:
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
Journal:
PLoS biology
Year of Publication:
2018
Pages:
str. 1-36
Volume and Issue Number:
vol. 16, iss. 9
ISSN Number:
1545-7885
DOI (Digital Object Identifier):
10.1371/journal.pbio.2006624
Researchers
Researchers
Meet our dedicated researchers behind this publication:
References
Access paper
Access the PDF publication document.
More documentation
Related publications
Browse all publications
